Skip to content

Ryan Cohlhepp, President and COO at Bicara Therapeutics, sold BCAX on Jul 8, 2026

Data as of Oct 27

▼ SELL$657K22,833 shares at $28.76Ryan Cohlhepp President and COOBCAX Bicara Therapeutics Inc.
Watch BCAX
Traded
Jul 8, 2026
Disclosed
Jul 10, 2026
Filed
2 days after the trade

Form 4s are due within two business days.

Official filing (SEC Form 4) ↗

The price around the disclosure

Ryan Cohlhepp, President and COO at Bicara Therapeutics, sold BCAX on Jul 8, 2026TRADEDDISCLOSED
BCAXSimilar stocks (XLV — its sector index fund), rebased to BCAX's price on the disclosure day
BCAX since disclosure
−39.5%
after the sale
Similar stocks (XLV) since disclosure
+11.4%
XLV — its sector index fund

Change in closing price from Jul 10, 2026 (the first trading day on or after disclosure) to Oct 27, 2026. Dividends excluded. Not a return anyone earned.

Our take

None of our tested rules fired on this trade.

Other trades in the same filing

  1. ▼ SELLRyan Cohlhepp President and COOBCAX Bicara Therapeutics Inc.$15.5Kdisclosed Jul 10 · filed 1 day after the trade
  2. ▼ SELLRyan Cohlhepp President and COOBCAX Bicara Therapeutics Inc.$32.6Kdisclosed Jul 10 · filed 2 days after the trade
  3. ▼ SELLRyan Cohlhepp President and COOBCAX Bicara Therapeutics Inc.$128Kdisclosed Jul 10 · filed 2 days after the trade

See every trade on BCAX →